flecainide has been researched along with Brain Vascular Disorders in 3 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Bortoli, A | 1 |
| Shi, LB | 1 |
| Ohm, OJ | 1 |
| Hoff, PI | 1 |
| Schuster, P | 1 |
| Solheim, E | 1 |
| Chen, J | 1 |
| Reeb, T | 1 |
| de Chillou, C | 1 |
| Sadoul, N | 1 |
| Lacour, JC | 1 |
| Ducrocq, X | 1 |
| Debouverie, M | 1 |
| Weber, M | 1 |
| Aliot, E | 1 |
| Guarnieri, T | 1 |
| Tomaselli, G | 1 |
| Griffith, LS | 1 |
| Brinker, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter[NCT03401099] | 113 participants (Actual) | Interventional | 2018-08-17 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for flecainide and Brain Vascular Disorders
| Article | Year |
|---|---|
Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter.
Topics: Aged; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Catheter Ablation | 2017 |
[Atrial electrophysiological study of unexplained ischemic cerebrovascular disorders].
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Cere | 1995 |
The interaction of antiarrhythmic drugs and the energy for cardioversion of chronic atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cerebrovascular Disorders; Chr | 1991 |